Artwork

Το περιεχόμενο παρέχεται από το TopHealth Media. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον TopHealth Media ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Player FM - Εφαρμογή podcast
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !

GLP-1 Beyond Weight Loss

49:12
 
Μοίρασέ το
 

Manage episode 454405760 series 3607289
Το περιεχόμενο παρέχεται από το TopHealth Media. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον TopHealth Media ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

Welcome to another episode of The Best Life Code! In today's show, Dr. Rudy dives deep into the fascinating world of GLP-1 medications. Approved by the FDA since 2005, these groundbreaking drugs offer an array of health benefits—reducing risks of Alzheimer's, heart disease, and diabetes, to name a few.
Despite their significant potential, GLP-1 medications often face stigmatization, especially when used for weight loss, an issue even celebrities like Oprah are hesitant to discuss. We'll explore how these medications work, tackling insulin resistance and inflammation at their core, and how they can redefine the concept of weight management and food addiction.
From compelling insights into the psychological boosts of early weight loss to the transformative impacts on aging and overall health, Dr. Rudy sheds light on why these drugs could be as revolutionary as penicillin. Join us as we discuss the economic implications, the evolving healthcare landscape, and Dr. Rudy's mixed feelings about the adoption of GLP-1 medications.
Plus, we'll look at real-life success stories and future innovations in metabolic and obesity medicine. This episode promises to be an eye-opener, shattering myths and providing a fresh perspective on achieving the best version of yourself. Stay tuned!
Timestamps:
00:00 Experience and Thanksgiving food moderated by GLP1 medications.
04:58 GLP1 medications effectively manage diabetes, replacing insulin.
07:28 FDA-approved WeGovy and Tirzepatide outperform Semaglutide.
12:39 Knowing what to do isn't doing it.
13:19 Addiction: Neurobiological issue, not willpower problem.
16:53 Patients with obesity experience difficult inner dialogue.
21:06 GLP1 medications have side effects, mitigate cautiously.
23:37 Microdosing optimizes health benefits, exercise prevents muscle loss.
26:22 Aging leads to belly fat, muscle loss.
29:10 GLP1s threaten junk food sales, altering consumption.
34:33 Subsidize GLP1 medication for metabolic crisis.
38:22 Semaglutide reduces Alzheimer's risk, despite stigma.
40:23 Patient improved greatly after GLP1 treatment introduction.
42:27 Future: oral GLP pills improve metabolic health.
47:00 More access to GLP1s for metabolic health.
3 Fun Facts:
1. Celebrity Influence: Even high-profile celebrities like Oprah have publicly acknowledged using GLP1 medications, highlighting the societal stigma around weight loss treatments.
2. Global Travel for Medications: Due to significant pricing disparity, many people travel internationally to purchase GLP1 medications at lower costs, illustrating the lengths individuals will go to for affordable healthcare.
3. Economic Shifts: GLP1 medications are impacting consumer behavior by reducing junk food consumption, potentially threatening industries like fast food and alcohol as people on these medications crave less unhealthy food and drink.

The Best Life Code Website - https://thebestlifecode.com/
Dr. Rudy's Website - https://drrudybestlife.com/
Dr. Rudy's Clinic's Website - https://drweightlossmiami.com/
TopHealth Media - https://tophealth.care/

  continue reading

5 επεισόδια

Artwork
iconΜοίρασέ το
 
Manage episode 454405760 series 3607289
Το περιεχόμενο παρέχεται από το TopHealth Media. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον TopHealth Media ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

Welcome to another episode of The Best Life Code! In today's show, Dr. Rudy dives deep into the fascinating world of GLP-1 medications. Approved by the FDA since 2005, these groundbreaking drugs offer an array of health benefits—reducing risks of Alzheimer's, heart disease, and diabetes, to name a few.
Despite their significant potential, GLP-1 medications often face stigmatization, especially when used for weight loss, an issue even celebrities like Oprah are hesitant to discuss. We'll explore how these medications work, tackling insulin resistance and inflammation at their core, and how they can redefine the concept of weight management and food addiction.
From compelling insights into the psychological boosts of early weight loss to the transformative impacts on aging and overall health, Dr. Rudy sheds light on why these drugs could be as revolutionary as penicillin. Join us as we discuss the economic implications, the evolving healthcare landscape, and Dr. Rudy's mixed feelings about the adoption of GLP-1 medications.
Plus, we'll look at real-life success stories and future innovations in metabolic and obesity medicine. This episode promises to be an eye-opener, shattering myths and providing a fresh perspective on achieving the best version of yourself. Stay tuned!
Timestamps:
00:00 Experience and Thanksgiving food moderated by GLP1 medications.
04:58 GLP1 medications effectively manage diabetes, replacing insulin.
07:28 FDA-approved WeGovy and Tirzepatide outperform Semaglutide.
12:39 Knowing what to do isn't doing it.
13:19 Addiction: Neurobiological issue, not willpower problem.
16:53 Patients with obesity experience difficult inner dialogue.
21:06 GLP1 medications have side effects, mitigate cautiously.
23:37 Microdosing optimizes health benefits, exercise prevents muscle loss.
26:22 Aging leads to belly fat, muscle loss.
29:10 GLP1s threaten junk food sales, altering consumption.
34:33 Subsidize GLP1 medication for metabolic crisis.
38:22 Semaglutide reduces Alzheimer's risk, despite stigma.
40:23 Patient improved greatly after GLP1 treatment introduction.
42:27 Future: oral GLP pills improve metabolic health.
47:00 More access to GLP1s for metabolic health.
3 Fun Facts:
1. Celebrity Influence: Even high-profile celebrities like Oprah have publicly acknowledged using GLP1 medications, highlighting the societal stigma around weight loss treatments.
2. Global Travel for Medications: Due to significant pricing disparity, many people travel internationally to purchase GLP1 medications at lower costs, illustrating the lengths individuals will go to for affordable healthcare.
3. Economic Shifts: GLP1 medications are impacting consumer behavior by reducing junk food consumption, potentially threatening industries like fast food and alcohol as people on these medications crave less unhealthy food and drink.

The Best Life Code Website - https://thebestlifecode.com/
Dr. Rudy's Website - https://drrudybestlife.com/
Dr. Rudy's Clinic's Website - https://drweightlossmiami.com/
TopHealth Media - https://tophealth.care/

  continue reading

5 επεισόδια

Όλα τα επεισόδια

×
 
Loading …

Καλώς ήλθατε στο Player FM!

Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.

 

Οδηγός γρήγορης αναφοράς